142280 — Green Cross Medical Science Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩86bn
- KR₩105bn
- KR₩94bn
- 39
- 29
- 20
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 13,688 | 4,503 | 1,843 | 10,751 | 5,744 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24,264 | 29,492 | 21,623 | 20,807 | 21,364 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 50,689 | 61,489 | 52,351 | 50,137 | 43,345 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 36,515 | 40,115 | 40,013 | 41,158 | 42,850 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 88,866 | 105,603 | 95,629 | 96,471 | 90,529 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 31,185 | 39,097 | 48,870 | 39,488 | 46,528 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 39,289 | 49,136 | 59,514 | 63,216 | 56,030 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 49,577 | 56,466 | 36,115 | 33,255 | 34,499 |
Total Liabilities & Shareholders' Equity | 88,866 | 105,603 | 95,629 | 96,471 | 90,529 |
Total Common Shares Outstanding |